ITOS (iTeos Therapeutics Inc) Sof foyda

ITOS (iTeos Therapeutics, Inc.) - kompaniyaning tovar belgisi

iTeos Therapeutics (ITOS) — bu ishlanmalarining gumanitar maqomi tufayli geosiyosiy xatarlarni minimallashtiradigan, yuqori terapiya samaradorligiga ega bo'lgan istiqbolli immuno-onkologiya brendidir. Kompaniyaning sof foydasi uning moliyaviy natijalarini aks ettiradi, bunda -0.21 ushbu ko'rsatkichning darajasini belgilaydi. Muvaffaqiyatlar innovatsion platformada saratonni davolash bo'yicha dadil g'oyalarni amalga oshirayotgan Belgiya va AQShdagi taniqli olimlar tomonidan ta'minlanmoqda.

ITOS (iTeos Therapeutics) Sof foyda tarixi 04.07.2022dan 14.09.2025gacha

iTeos Therapeutics, Inc. (ITOS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari iTeos Pharma|ITOS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi iTeos Pharma|ITOS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati iTeos Therapeutics|ITOS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi iteostherapeutics.com|ITOS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati iTeos Therapeutics|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati iTeos Therapeutics Inc|ITOS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar iTeos Pharma|ITOS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi iTeos Therapeutics|Shoshilinch likvidlik iteostherapeutics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ITOS - Sof foyda
Kompaniyaning jamlanma tahlili:iTeos Therapeutics
iTeos asosiy tovari

iTeos Therapeutics kompaniyasining foydasi umumiy daromadlar va barcha operatsion xarajatlar o'rtasidagi farqni aks ettiradi, bu esa xarajatlarni boshqarish samaradorligini va dividendlar to'lash potentsialini baholash imkonini beradi. R&D sohasiga investitsiyalar kiritadigan va olimlarni aksiyalar opsionlari orqali jalb qiladigan iTeos Therapeutics uchun grafikdagi sof natijalar onko-immunologiya rivojlantirish xarajatlari va yaratilayotgan antitelarning bozor qiymati o'rtasidagi muvozanatning ko'rsatkichi bo'lib xizmat qiladi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Sof daromad|UPB: Soliqlar to‘langandan keyingi foyda|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Septerna Inc SEPN|Sof moliyaviy natija pieris.com (PVLA)|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Sof daromad|ATXS: Soliqlar to‘langandan keyingi foyda|ENGN (enGene Holdings Inc.) - Sof foyda|RAPT: Yakuniy foyda|Sof foyda JBIO|ACRS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Kyverna KYTX|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Sof foyda|Kompaniyaning sof daromadi Agenus, Inc AGEN|Sof daromad CLYM (Climb Bio Inc)|Sof foyda zurabio.com (ZURA)|aTyr Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda ADAG (Adagene Inc)|Ikena Oncology, Inc. - Sof foyda|Sof moliyaviy natija Shattuck Labs, Inc. STTK|EQ: Sof foyda|Sof daromad Connect Biopharma Holdings Limited|Kompaniyaning sof foydasi Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|Sof moliyaviy natija X4 Pharmaceuticals, Inc|Adicet Bio, Inc. - Sof daromad|Soliqlar to‘langandan keyingi foyda CELU (Celularity Inc)|INMB - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|SABS - Sof moliyaviy natija|Kompaniyaning sof foydasi Akari Therapeutics|Enlivex Therapeutics, Ltd. - Soliqdan keyingi foyda|Sof foyda QTTB|GOVX (GeoVax Labs) - Yakuniy foyda|Sof foyda EDSA (Edesa)|Sof foyda iBio Corporation IBIO|CARM - Kompaniyaning sof foydasi|Yakuniy foyda XTLB (xtlbio.com)|boltbio.com (BOLT) - Kompaniyaning sof foydasi|Sof daromad HCW Biologics|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|Sof foyda aimimmuno.com|Sof daromad ADTX (Aditxt)|GRI (gribio.com) - Yakuniy foyda|Sof foyda XRTX (XORTX Therapeutics)|Sof moliyaviy natija Vyome Holdings Inc. (HIND)|REVB - Kompaniyaning sof foydasi|Indaptus Corp (INDP) - Sof daromad|Scinai Immunotherapeutics (SCNI) - Kompaniyaning sof foydasi|Sof daromad CalciMedica|Sof daromad AFMD|Sof foyda Allakos Therapeutics|Kompaniyaning sof foydasi HOOKIPA Pharma Inc. (HOOK)|igmbio.com - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|Third Harmonic Bio, Inc. - Sof foyda